vs
Side-by-side financial comparison of HEALTHSTREAM INC (HSTM) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $79.7M, roughly 2.0× HEALTHSTREAM INC). On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 7.4%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $13.0M).
HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
HSTM vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.7M | $158.6M |
| Net Profit | — | $112.9M |
| Gross Margin | — | — |
| Operating Margin | 3.0% | 70.2% |
| Net Margin | — | 71.2% |
| Revenue YoY | 7.4% | 3661.1% |
| Net Profit YoY | — | 528.0% |
| EPS (diluted) | $0.09 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.7M | — | ||
| Q3 25 | $76.5M | — | ||
| Q2 25 | $74.4M | — | ||
| Q1 25 | $73.5M | $158.6M | ||
| Q4 24 | $74.2M | $22.6M | ||
| Q3 24 | $73.1M | — | ||
| Q2 24 | $71.6M | — | ||
| Q1 24 | $72.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | $6.1M | — | ||
| Q2 25 | $5.4M | — | ||
| Q1 25 | $4.3M | $112.9M | ||
| Q4 24 | — | $-10.5M | ||
| Q3 24 | $5.7M | — | ||
| Q2 24 | $4.2M | — | ||
| Q1 24 | $5.2M | — |
| Q4 25 | 3.0% | — | ||
| Q3 25 | 9.9% | — | ||
| Q2 25 | 7.9% | — | ||
| Q1 25 | 6.0% | 70.2% | ||
| Q4 24 | 6.3% | -60.4% | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 7.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 8.0% | — | ||
| Q2 25 | 7.2% | — | ||
| Q1 25 | 5.9% | 71.2% | ||
| Q4 24 | — | -46.4% | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | 7.2% | — |
| Q4 25 | $0.09 | — | ||
| Q3 25 | $0.20 | — | ||
| Q2 25 | $0.18 | — | ||
| Q1 25 | $0.14 | $1.90 | ||
| Q4 24 | $0.16 | $-0.15 | ||
| Q3 24 | $0.19 | — | ||
| Q2 24 | $0.14 | — | ||
| Q1 24 | $0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.2M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $354.0M | $350.1M |
| Total Assets | $520.4M | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.2M | — | ||
| Q3 25 | $53.5M | — | ||
| Q2 25 | $52.1M | — | ||
| Q1 25 | $77.3M | $274.8M | ||
| Q4 24 | $59.5M | $128.0M | ||
| Q3 24 | $57.5M | — | ||
| Q2 24 | $46.1M | — | ||
| Q1 24 | $52.4M | — |
| Q4 25 | $354.0M | — | ||
| Q3 25 | $349.2M | — | ||
| Q2 25 | $350.6M | — | ||
| Q1 25 | $362.8M | $350.1M | ||
| Q4 24 | $359.4M | $229.0M | ||
| Q3 24 | $355.5M | — | ||
| Q2 24 | $349.2M | — | ||
| Q1 24 | $344.9M | — |
| Q4 25 | $520.4M | — | ||
| Q3 25 | $499.9M | — | ||
| Q2 25 | $500.1M | — | ||
| Q1 25 | $524.0M | $406.9M | ||
| Q4 24 | $510.8M | $271.6M | ||
| Q3 24 | $502.8M | — | ||
| Q2 24 | $499.6M | — | ||
| Q1 24 | $511.6M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.2M | $131.8M |
| Free Cash FlowOCF − Capex | $13.0M | $131.7M |
| FCF MarginFCF / Revenue | 16.3% | 83.0% |
| Capex IntensityCapex / Revenue | 0.3% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $59.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.2M | — | ||
| Q3 25 | $18.0M | — | ||
| Q2 25 | $5.0M | — | ||
| Q1 25 | $27.1M | $131.8M | ||
| Q4 24 | $11.2M | $-23.2M | ||
| Q3 24 | $19.1M | — | ||
| Q2 24 | $6.5M | — | ||
| Q1 24 | $20.9M | — |
| Q4 25 | $13.0M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.7M | — | ||
| Q1 25 | $26.0M | $131.7M | ||
| Q4 24 | $11.0M | $-23.2M | ||
| Q3 24 | $18.8M | — | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $20.2M | — |
| Q4 25 | 16.3% | — | ||
| Q3 25 | 23.4% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | 35.4% | 83.0% | ||
| Q4 24 | 14.8% | -102.7% | ||
| Q3 24 | 25.8% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | 27.8% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 1.4% | 0.1% | ||
| Q4 24 | 0.3% | 0.2% | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.96× | — | ||
| Q2 25 | 0.93× | — | ||
| Q1 25 | 6.25× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.34× | — | ||
| Q2 24 | 1.55× | — | ||
| Q1 24 | 4.01× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HSTM
| Subscription Services | $77.0M | 97% |
| Professional Services | $2.7M | 3% |
STOK
Segment breakdown not available.
